Gupta B, Johnson NW, Kumar N. Global epidemiology of head and neck cancers: A continuing challenge. Oncology. 2016;91:13–23. https://doi.org/10.1159/000446117.
Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol. 2006;24(17):2618–23. https://doi.org/10.1200/JCO.2005.04.7225.
Marta GN, Silva V, de Andrade Carvalho H, et al. Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis. Radiother Oncol. 2014;110(1):9–15. https://doi.org/10.1016/j.radonc.2013.11.010.
Mackeprang PH, Bryjova K, Heusel AE, et al. EORTC Head & Neck Young Investigators Group. Consideration of image guidance in patterns of failure analyses of intensity-modulated radiotherapy for head and neck cancer: a systematic review. Radiat Oncol. 2024;9(1):30. https://doi.org/10.1186/s13014-024-02421-w.
Fried DV, Zanation AM, Huang B, et al. Patterns of local failure for sinonasal malignancies. Practical Radiation Oncol. 2013;3:e113–20.
Orlandi E, Tomatis S, Potepan P, et al. Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma. Future Oncol. 2013;9(1):103–14. https://doi.org/10.2217/fon.12.166.
Article CAS PubMed Google Scholar
Cannon DM, Lee NY. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;70(3):660–5. https://doi.org/10.1016/j.ijrobp.2007.09.018.
Navran A, Heemsbergen W, Janssen T, et al. The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT). Radiother Oncol. 2019;130:25–31. https://doi.org/10.1016/j.radonc.2018.06.032.
van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004;14(1):52–64. https://doi.org/10.1053/j.semradonc.2003.10.003.
ICRU Report 62. Prescribing, Recording, and Reporting Photon Beam Therapy (Supplement to ICRU Report 50) International Commission on Radiation Units and Measurements. 1999.
ICRU Report 83. Prescribing, recording, and reporting intensity-modulated photon-beam therapy (IMRT) (ICRU Report 83) International Commission on Radiation Units and Measurements, Bethesda, MD, 2010.
Garden AS, Harris J, Eisbruch A, et al. Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. 2023;117(2):333–40. https://doi.org/10.1016/j.ijrobp.2023.02.057.
Article PubMed PubMed Central Google Scholar
Gregoire V, Evans M, Le QT et al. (2018) Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiother Oncol. 126(1):3–24 https://doi.org/10.1016/j.radonc.2017.10.016
Van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47(4):1121–35. https://doi.org/10.1016/s0360-3016(00)00518-6.
Stroom JC, De Boer HC, Huizenga H, Visser AG. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. Int J Radiat Oncol Biol Phys. 1999;43(4):905–19. https://doi.org/10.1016/s0360-3016(98)00468-4.
Article CAS PubMed Google Scholar
McKenzie A, van Herk M, Mijnheer B. Margins for geometric uncertainty around organs at risk in radiotherapy. Radiother Oncol. 2002;62(3):299–307. https://doi.org/10.1016/s0167-8140(02)00015-4.
Humphreys M, Guerrero Urbano MT, Mubata C, et al. Assessment of a customised immobilisation system for head and neck IMRT using electronic portal imaging. Radiother Oncol. 2005;77(1):39–44. https://doi.org/10.1016/j.radonc.2005.06.039.
Gupta T, Chopra S, Kadam A, et al. Assessment of three-dimensional setup errors in conventional head and neck radiotherapy using electronic portal imaging device. Radiat Oncol. 2007;2:44. https://doi.org/10.1186/1748-717X-2-44.
Article PubMed PubMed Central Google Scholar
Rudat V, Hammoud M, Pillay Y, et al. Impact of the frequency of online verifications on the patient set-up accuracy and set-up margins. Radiat Oncol. 2011;6:101. https://doi.org/10.1186/1748-717x-6-101.
Article PubMed PubMed Central Google Scholar
Mongioj V, Orlandi E, Palazzi M, al. Set-up errors analyses in IMRT treatments for nasopharyngeal carcinoma to evaluate time trends, PTV and PRV margins. Acta Oncol. 2011;50(1):61–71. https://doi.org/10.3109/0284186x.2010.509108.
Juan-Senabre XJ, López-Tarjuelo J, Conde-Moreno A, et al. Uncertainties and CTV to PTV margins quantitative assessment using cone-beam CT technique in clinical application for prostate, and head and neck irradiation tumours. Clin Transl Oncol. 2011;13(11):819–25. https://doi.org/10.1007/s12094-011-0740-8.
Article CAS PubMed Google Scholar
Strbac B, Jokic VS. Evaluation of set-up errors in head and neck radiotherapy using electronic portal imaging. Phys Med. 2013;29(5):531–6. 10.1016/j. ejmp.2012.12.001.
Qi XS, Hu AY, Lee SP, et al. Assessment of interfraction patient setup for head-and-neck cancer intensity modulated radiation therapy using multiple computed tomography-based image guidance. Int J Radiat Oncol Biol Phys. 2013;86(3):432–9. https://doi.org/10.1016/j.ijrobp.2013.01.022.
Oh YK, Baek JG, Kim OB, et al. Assessment of setup uncertainties for various tumor sites when using daily CBCT for more than 2200 VMAT treatments. J Appl Clin Med Phys. 2014;15(2):4418. https://doi.org/10.1120/jacmp.v15i2.4418.
Article PubMed PubMed Central Google Scholar
Dzierma Y, Beyhs M, Palm J, et al. Set-up errors and planning margins in planar and CBCT image-guided radiotherapy using three different imaging systems: A clinical study for prostate and head-and-neck cancer. Phys Med. 2015;31(8):1055–9. https://doi.org/10.1016/j.ejmp.2015.09.002.
Saha A, Mallick I, Das P, et al. Evaluating the need for daily image guidance in head and neck cancers treated with helical tomotherapy: A retrospective analysis of a large number of daily imaging-based corrections. Clin Oncol. 2016;28(3):178–84. https://doi.org/10.1016/j.clon.2015.11.014.
Cubillos Mesias M, Boda-Heggemann J, Thoelking J, et al. Quantification and assessment of interfraction setup errors based on cone beam CT and determination of safety margins for radiotherapy. PLoS ONE. 2016;11(3):e0150326. https://doi.org/10.1371/journal.pone.0150326.
Article CAS PubMed PubMed Central Google Scholar
Delishaj D, Ursino S, Pasqualetti F, et al. Set-up errors in head and neck cancer treated with IMRT technique assessed by cone-beam computed tomography: A feasible protocol. Radiat Oncol J. 2018;36(1):54–62. https://doi.org/10.3857/roj.2017.00493.
Article PubMed PubMed Central Google Scholar
Youssoufi MA, Bougtib M, Douama S, et al. Evaluation of PTV margins in IMRT for head and neck cancer and prostate cancer. J Radiother Pract. 2021;20:114–19. https://doi.org/10.1017/S1460396919000931.
Deb J, Chaudhuri S, Panda D, et al. Retrospective analysis of random and systematic errors in radiation therapy of head and neck cancer patients and its clinical predictive implications with VMAT treatment. Int J Res Med Sci. 2019;7:2758–63. https://doi.org/10.18203/2320-6012.ijrms20192914.
Alabedi H. Assessing setup errors and shifting margins for planning target volume in head, neck, and breast cancer. J Med Life. 2023;16:394–8. https://doi.org/10.25122/jml-2022-0241.
Article PubMed PubMed Central Google Scholar
Aher M, Chirkute M, Kale P, et al. Planning target volume margin in head and neck cancer patients undergoing radiation therapy: Estimations derived from own data and literature. Med Dos. 2024;49(3):192–7. https://doi.org/10.1016/j.meddos.2023.12.001.
Lee NY, Zhang Q, Pfister DG, et al. Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial. Lancet Oncol. 2012;13(2):172–80. https://doi.org/10.1016/S1470-2045(11)70303-5.
Comments (0)